Trade Exagen Inc. - XGN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0348 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.8326 |
| Open | 5.5826 |
| 1-Year Change | 312.46% |
| Day's Range | 5.5826 - 6.1926 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 6.1826 | 0.3400 | 5.82% | 5.8426 | 6.2126 | 5.5826 |
| Apr 24, 2025 | 5.8326 | 0.2300 | 4.11% | 5.6026 | 6.0326 | 5.3926 |
| Apr 23, 2025 | 5.6126 | 0.6200 | 12.42% | 4.9926 | 5.7126 | 4.9926 |
| Apr 22, 2025 | 4.8126 | 0.3200 | 7.12% | 4.4926 | 4.9026 | 4.4926 |
| Apr 21, 2025 | 4.4126 | 0.0600 | 1.38% | 4.3526 | 4.5126 | 4.2726 |
| Apr 17, 2025 | 4.4526 | -0.0400 | -0.89% | 4.4926 | 4.4926 | 4.1126 |
| Apr 16, 2025 | 4.4326 | 0.0500 | 1.14% | 4.3826 | 4.5926 | 4.3826 |
| Apr 15, 2025 | 4.4026 | 0.0700 | 1.62% | 4.3326 | 4.6426 | 4.3026 |
| Apr 14, 2025 | 4.5126 | 0.2900 | 6.87% | 4.2226 | 4.6326 | 4.1726 |
| Apr 11, 2025 | 4.2326 | 0.2300 | 5.75% | 4.0026 | 4.4026 | 4.0026 |
| Apr 10, 2025 | 4.1226 | -0.0700 | -1.67% | 4.1926 | 4.3626 | 3.9926 |
| Apr 9, 2025 | 4.3626 | 0.4600 | 11.79% | 3.9026 | 4.5326 | 3.8926 |
| Apr 8, 2025 | 3.9926 | -0.1000 | -2.44% | 4.0926 | 4.2126 | 3.8426 |
| Apr 7, 2025 | 4.0626 | 0.2500 | 6.56% | 3.8126 | 4.2426 | 3.7326 |
| Apr 4, 2025 | 3.9926 | 0.0400 | 1.01% | 3.9526 | 4.1226 | 3.8226 |
| Apr 3, 2025 | 4.2626 | 0.1700 | 4.15% | 4.0926 | 4.2826 | 3.8726 |
| Apr 2, 2025 | 4.3926 | 0.5700 | 14.91% | 3.8226 | 4.6026 | 3.8226 |
| Apr 1, 2025 | 3.8826 | 0.3500 | 9.91% | 3.5326 | 4.1026 | 3.3926 |
| Mar 31, 2025 | 3.5726 | -0.1200 | -3.25% | 3.6926 | 3.6926 | 3.1626 |
| Mar 28, 2025 | 3.8326 | -0.2100 | -5.19% | 4.0426 | 4.3126 | 3.6926 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Exagen Inc. Company profile
About Exagen Inc
Exagen Inc. is a commercial-stage life sciences company. The Company offers physicians testing for patients and healthcare providers in diagnosis, prognosis, and monitoring of autoimmune conditions. The Company develops and commercialize testing products under the brand name AVISE. The Company's lead testing product AVISE enables diagnosis for patients with symptoms of connective tissue diseases ( CTD) and Systemic lupus erythematosus (SLE). Its other diagnostic testing includes AVISE Lupus and AVISE antiphospholipid syndrome (APS). Its Prognosis tests include AVISE systemic lupus erythematosus (SLE) Prognostic, AVISE Anti- carbamylated proteins (CarP) and AVISE Platelet-bound C4d (PC4d). Its monitoring tests include AVISE SLE Monitor, AVISE methotrexate (MTX) and AVISE hydroxychloroquine (HCQ).
Financial summary
BRIEF: For the nine months ended 30 September 2021, Exagen Inc revenues increased 22% to $35.6M. Net loss increased 50% to $19.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Selling, general & administrative exp increase from $200K to $28.5M (expense), Other income / (expense), net decrease of 100% to $1K (income).
| Industry: | Healthcare Facilities & Services (NEC) |
1261 Liberty Way Ste C
VISTA
CALIFORNIA 92081-8356
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com